Antibodies to voltage-gated potassium and calcium channels in epilepsy

Epilepsy Research

Volumn 71, Issue 2-3, 2006, Pages 135-141

  Majoie, H J Marian ^a,b,c   de Baets, Mark ^b,c   Renier, Willy ^a,d   Lang, Bethan ^e   Vincent, Angela ^e  

^a EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Autoantibodies; Epilepsy; Voltage gated ion channels

Indexed keywords

ANTIBODY; ANTICONVULSIVE AGENT; AUTOANTIBODY; BENZODIAZEPINE; CARBAMAZEPINE; CLOBAZAM; CLORAZEPATE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; GLUTAMATE DECARBOXYLASE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL;

ADOLESCENT; ADULT; AMNESIA; ANAMNESIS; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; ENCEPHALITIS; EPILEPSY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIMBIC CORTEX; MAJOR CLINICAL STUDY; MEDICAL INFORMATICS; MENTAL PATIENT; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SERUM;

ADOLESCENT; ADULT; AUTOANTIBODIES; CALCIUM CHANNELS; EPILEPSY; FEMALE; HUMANS; MIDDLE AGED; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 33748865734     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2006.06.003     Document Type: Article

References (27)

1. Anon., 2006. Website: MICROMEDEX Healthcare Series. Drugdex Consults, Thomson, http://www.micromedex.com/products/drugdex/.
2. Avanzini G., and Ptacek L.J. In: Guerrini R., Aicardi J., Andermann F., and Hallett M. (Eds). Epilepsies and Channelopathies. Epilepsy and Movement Disorders (2002), Cambridge University Press, Cambridge 1-14
3. Buckley C., Oger J., et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann. Neurol. 50 1 (2001) 73-78
4. Chang B.S., and Lowenstein D.H. Epilepsy. N. Engl. J. Med. 349 13 (2003) 1257-1266
5. Chong J.Y., Rowland L.P., et al. Hashimoto encephalopathy: syndrome or myth?. Arch. Neurol. 60 2 (2003) 164-171
6. Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 (1981) 489-501
7. Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 4 (1989) 389-399
8. Dalmau J., Gultekin H.S., et al. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol. 9 2 (1999) 275-284
9. Giometto B., Nicolao P., et al. Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 352 9126 (1998) 457
10. Gonzalez F.J., Carvajal M.J., et al. Erythema multiforme to phenobarbital: involvement of eosinophils and T cells expressing the skin homing receptor. J. Allergy Clin. Immunol. 100 1 (1997) 135-137
11. Hart I.K., Maddison P., et al. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125 Pt. 8 (2002) 1887-1895
12. + channels are implicated in neuromyotonia. Ann. Neurol. 41 2 (1997) 238-246
13. Leeder J.S. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs. Epilepsia 39 Suppl. 7 (1998) S8-S16
14. McKnight K., Jiang Y., et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65 (2005) 1730-1735
15. Motomura M., Johnston I., et al. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J. Neurol. Neurosurg. Psychiatr. 58 1 (1995) 85-87
16. Moulard B., Picard F., et al. Ion channel variation causes epilepsies. Brain Res. Brain Res. Rev. 36 2/3 (2001) 275-284
17. Naisbitt D.J., Britschgi M., et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol. Pharmacol. 63 3 (2003) 732-741
18. Naisbitt D.J., Farrell J., et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J. Allergy Clin. Immunol. 111 6 (2003) 1393-1403
19. Peltola J., Kulmala P., et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55 1 (2000) 46-50
20. Ptacek L.J., and Fu Y.H. Channelopathies: episodic disorders of the nervous system. Epilepsia 42 Suppl. 5 (2001) 35-43
21. Shorvon S. Handbook of Epilepsy Treatment (2000), Blackwell Science, Oxford
22. Solinger A.M. Drug-related lupus. Clinical and etiologic considerations. Rheum. Dis. Clin. N. Am. 14 1 (1988) 187-202
23. Song C., and Leonard B.E. Fundamentals of Psychoneuroimmunology (2000), John Wiley and Sons, Chichester
24. Thieben M.J., Lennon V.A., et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62 7 (2004) 1177-1182
25. Travin M., Macris N.T., et al. Reversible common variable immunodeficiency syndrome induced by phenytoin. Arch. Intern. Med. 149 6 (1989) 1421-1422
26. van Engelen B.G., Weemaes C.M., et al. A dysbalanced immune system in cryptogenic Lennox-Gastaut syndrome. Scand. J. Immunol. 41 2 (1995) 209-213
27. Vincent A., Buckley C., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127 Pt. 3 (2004) 701-712